Nasdaq Drops 200 Points; Meta Platforms Shares Jump
U.S. stocks traded lower toward the end of trading , with the Nasdaq Composite dropping 200 points on Wednesday.
Crude Oil Down Over 2%; Outset Medical Shares Spike Higher
U.S. stocks traded lower midway through trading as investors focused on the outcome of the midterm elections.
Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Ipsen Announced Onivyde Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma; Trial Met its Primary Endpoint and Key Secondary Endpoint
Ipsen (Euronext: IPN; ADR: IPSEY) announced the Phase III NAPOLI 3 trial of Onivyde® (irinotecan liposome injection) plus 5 fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) met its primary endpoint demonstrating clinically meaningful and statistically significant improvement in overall survival compared to nab-paclitaxel plus gemcitabine in 770 previously untreated patients with metasta
Merrimack Pharmaceuticals Q3 EPS $(0.03) Up From $(0.04) YoY
Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly earnings of $(0.03) per share. This is a 175 percent increase over losses of $(0.04) per share from the same period last year.
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Gainers
Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 528 companies set new 52-week lows.